Amy Cayne Schwartz is spearheading operations, business strategy and is the General Counsel for Pearl Bio. Ms. Schwartz is also the President and General Counsel of Genome Project-write (GP-write), a non-profit global consortium, where she oversees the technology development of a foundry and startup ecosystem for genome writing, including the creation of a first-of-its kind computational genome design platform. To translate these efforts, Amy has established partnerships with life science companies, venture firms and accelerators. Amy also serves as a biotechnology consultant for life science ventures. Prior to her work in the life sciences, Amy was an attorney at Cadwalader, Wickersham & Taft and Nixon Peabody. Amy holds a BA in Political Science from the University of Pennsylvania and studied at the London School of Economics (LSE). She earned a JD from Fordham University School of Law, where she was a member of the Intellectual Property, Media and Entertainment Law Journal, and has completed coursework in Biomanufacturing at M.I.T.
